Iaso Ventures

About Iaso Ventures

Iaso Ventures is a Boston-based early-stage healthcare venture capital firm with a primary focus on brain health innovations. Their investment portfolio spans a wide range of healthcare solutions, including digital biomarkers and therapeutics, medical technology, mobile health solutions, healthcare information technology, and robust data analytics capabilities. They prioritize game-changing startups dedicated to curing diseases and improving patient outcomes. With a patient-centric investment philosophy, they aim to catalyze biodigital innovation for next-gen life sciences. Iaso Ventures actively seeks companies at the intersection of technology and healthcare that are leveraging data-driven enabling technologies and platforms to support the development of new therapeutics. Their fund specialties include Early, Seed, Series A, and Pre-seed stages, targeting investments between $100,000 and $2,500,000 with a keen interest in contributions around $500,000. The firm currently manages assets worth $50,000,000. As part of their value proposition, Iaso Ventures operates Iaso Venture Studio, utilizing its sector-specific expertise to incubate, accelerate, and scale startups in their niche. This collaborative approach is underpinned by their investor-operator DNA and industry-wide connections, aiming to maximize value creation and growth. Their strategic partner network provides a robust ecosystem for fostering innovation. Iaso Ventures' name derives inspiration from Greek mythology's Iaso, the goddess of recuperation, emblematic of the firm's commitment to restoring health and wellness through cutting-edge healthcare solutions.